Compare PVLA & CNOB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PVLA | CNOB |
|---|---|---|
| Founded | 2015 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.2B |
| IPO Year | N/A | 1996 |
| Metric | PVLA | CNOB |
|---|---|---|
| Price | $102.42 | $26.85 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 16 | 2 |
| Target Price | ★ $141.50 | $29.50 |
| AVG Volume (30 Days) | 292.1K | ★ 294.9K |
| Earning Date | 11-11-2025 | 01-29-2026 |
| Dividend Yield | N/A | ★ 2.68% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.30 |
| Revenue | N/A | ★ $295,956,000.00 |
| Revenue This Year | N/A | $47.80 |
| Revenue Next Year | N/A | $31.81 |
| P/E Ratio | ★ N/A | $20.65 |
| Revenue Growth | N/A | ★ 19.03 |
| 52 Week Low | $11.17 | $20.61 |
| 52 Week High | $114.69 | $28.47 |
| Indicator | PVLA | CNOB |
|---|---|---|
| Relative Strength Index (RSI) | 56.83 | 54.21 |
| Support Level | $99.00 | $26.36 |
| Resistance Level | $114.69 | $28.47 |
| Average True Range (ATR) | 8.59 | 0.69 |
| MACD | 0.18 | -0.12 |
| Stochastic Oscillator | 62.78 | 34.64 |
Palvella Therapeutics Inc is a late clinical-stage biopharmaceutical company committed to serving individuals suffering from serious, rare genetic skin diseases without approved therapies. The Company's lead product candidate, QTORIN 3.9 percent rapamycin anhydrous gel (QTORIN rapamycin), is based on the Company's patented QTORIN platform. QTORIN rapamycin is in clinical development for two rare genetic skin disorders.
ConnectOne Bancorp Inc is a community-based, full-service New Jersey-chartered commercial bank. Substantially all loans are secured with various types of collateral, including business assets, consumer assets and commercial/residential real estate. Each borrower's ability to repay its loans is dependent on the conversion of assets, cash flows generated from the borrowers' business, real estate rental and consumer wages.